Journal
INTERNATIONAL IMMUNOPHARMACOLOGY
Volume 54, Issue -, Pages 385-400Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.intimp.2017.11.036
Keywords
NOD1; NOD2; Muropeptides; Infectious diseases; Innate immunity; Mucosal immunity
Categories
Funding
- Russian Science Foundation [16-15-10314]
- Russian Science Foundation [16-15-10314] Funding Source: Russian Science Foundation
Ask authors/readers for more resources
Nucleotide-binding oligomerization domain (NOD) 1 and NOD2 are pattern-recognition receptors responsible for sensing fragments of bacterial peptidoglycan known as muropeptides. Stimulation of innate immunity by systemic or local administration of NOD1 and NOD2 agonists is an attractive means to prevent and treat infectious diseases. In this review, we discuss novel data concerning structural features of selective and nonselective (dual) NOD1 and NOD2 agonists, main signaling pathways and biological effects induced by NOD1 and NOD2 stimulation, including induction of pro-inflammatory cytokines, type I interferons and antimicrobial peptides, induction of autophagy, alterations of metabolism. We also discuss interactions between NOD1/NOD2 and Toll-like receptor agonists in terms of synergy and cross-tolerance. Finally, we review available animal data on the role of NOD1 and NOD2 in protection against infections, and discuss how these data could be applied in human infectious diseases.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available